Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Viral Immunology|August 18, 2010
A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strainsMerijn Vanhee, Sarah Costers, Wander Van Breedam, et al.
BMC Veterinary Research|October 4, 2012
Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challengesMarc F Geldhof, Merijn Vanhee, Wander Van Breedam, et al.
Microbial Pathogenesis|April 23, 2011
Porcine reproductive and respiratory syndrome virus (PRRSV) causes apoptosis during its replication in fetal implantation sitesUladzimir U Karniychuk, Dipongkor Saha, Marc Geldhof, et al.
American Journal of Clinical Pathology|November 1, 2021
Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 LineageDieter De Smet, Merijn Vanhee, Brigitte Maes, et al.
Infectious Diseases (London, England)|May 31, 2022
Pitfalls of SARS-CoV-2 antigen testing at emergency departmentEleonora Cottone, Frederik Van Hoecke, Geert Antoine Martens, et al.
Virologica Sinica|June 22, 2014
Unusual outcome of in utero infection and subsequent postnatal super-infection with different PCV2b strainsDipongkor Saha, Uladzimir U Karniychuk, Liping Huang, et al.
Veterinary Microbiology|September 18, 2013
Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccinesMarc F Geldhof, Wander Van Breedam, Ellen De Jong, et al.
Veterinary Immunology and Immunopathology|April 8, 2011
Porcine reproductive and respiratory syndrome virus (PRRSV)-specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virusWander Van Breedam, Sarah Costers, Merijn Vanhee, et al.
Frontiers in Immunology|January 24, 2022
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion PeptideNathalie Vanderheijden, Annelies Stevaert, Jiexiong Xie, et al.
Viruses|December 23, 2022
Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised HostsLouis Nevejan, Sien Ombelet, Lies Laenen, et al.
Pageof 3